GNBTQ

Generex Biotechnology Corp

GNBTQ · OTC · Commercial Services, Miscellaneous Commercial Services

Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies.

Current Price
—
Market Cap
—
Return Since Last Split
—
Last Split
Feb 25, 2020
Total Splits
1
Cumulative Multiple
1.4×

What If You Bought GNBTQ Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
140 shares · 1×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Feb 25, 2020—7-for-51.4×1.4×

Generex Biotechnology Corp Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Generex Biotechnology Corp's latest record in the split calendar is a 7-for-5 forward split effective 2020-02-25.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.